Alpha-Stim AID Cranial Electrotherapy Stimulation (CES) Anxiety and Depression Treatment for Adults in a Social Prescribing Service: Anxiety and Depression Outcomes
Background: Generalised anxiety disorder (GAD) is common and can negatively impact people’s wellbeing and functioning. GAD treatment includes psychotherapy and/or anti-anxiety medication, which are not acceptable to or effective for many people experiencing GAD. Alpha-Stim AID cranial electrotherapy stimulation (CES) has evidence of effectiveness in the treatment of anxiety and depression. Purpose: Evaluation of Alpha-Stim AID on anxiety and depression for adults with GAD symptoms using a social prescribing service. Methods: An open-label patient cohort design with no control group. Twenty-six adult patients, 22 females and 4 males, with an age range of 24 to 68 years and an average age of 49 years, completed 6 weeks of Alpha-Stim AID use. Pre- and post-intervention assessments were undertaken using participant self-report measures: Generalised Anxiety Disorder (GAD-7) and Patient Health Questionnaire (PHQ-9). Results: Reliable improvement and remission rates were 42% and 19% for GAD-7; 38% and 27% for PHQ-9. GAD-7 and PHQ-9 significantly improved with large effect sizes. Conclusions: A social prescribing service can offer, and patients will choose to use Alpha-Stim AID, which may be useful in the treatment of anxiety and depression. This study addresses the need for real-world data on Alpha-Stim AID in relation to response rates. It contributes to how Alpha-Stim Aid can be used in social prescribing services, including through a group-based pathway.
References
[1]
Amendola, S., Plöderl, M., & Hengartner, M. P. (2024). Suicide Rates and Prescription of Antidepressants. Crisis, 45, 225-233. https://doi.org/10.1027/0227-5910/a000941
[2]
APA (2013). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, 21, 591-643.
[3]
Bandelow, B., & Michaelis, S. (2015). Epidemiology of Anxiety Disorders in the 21st Century. Dialogues in Clinical Neuroscience, 17, 327-335. https://doi.org/10.31887/dcns.2015.17.3/bbandelow
[4]
Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of Anxiety Disorders. Dialogues in Clinical Neuroscience, 19, 93-107. https://doi.org/10.31887/dcns.2017.19.2/bbandelow
[5]
Barclay, T. H., & Barclay, R. D. (2014). A Clinical Trial of Cranial Electrotherapy Stimulation for Anxiety and Comorbid Depression. Journal of Affective Disorders, 164, 171-177. https://doi.org/10.1016/j.jad.2014.04.029
[6]
Bespalov, A. Y., van Gaalen, M. M., & Gross, G. (2010). Antidepressant Treatment in Anxiety Disorders. In Current Topics in Behavioral Neurosciences (pp. 361-390). Springer. https://doi.org/10.1007/785420093
[7]
Brunyé, T. T., Patterson, J. E., Wooten, T., & Hussey, E. K. (2021). A Critical Review of Cranial Electrotherapy Stimulation for Neuromodulation in Clinical and Non-Clinical Samples. Frontiers in Human Neuroscience, 15, Article 625321. https://doi.org/10.3389/fnhum.2021.625321
[8]
Burke, M. J. (2023). A Fundamental Change Is Needed for Appraising Placebo Responses in Psychiatry. The Lancet Psychiatry, 10, 316-317. https://doi.org/10.1016/s2215-0366(23)00068-8
[9]
Carter, R. M., Wittchen, H., Pfister, H., & Kessler, R. C. (2001). One-Year Prevalence of Subthreshold and Threshold DSM-IV Generalized Anxiety Disorder in a Nationally Representative Sample. Depression and Anxiety, 13, 78-88. https://doi.org/10.1002/da.1020
[10]
Castaldelli-Maia, J. M., Scomparini, L. B., Andrade, A. G. D., Bhugra, D., de Toledo Ferraz Alves, T. C., & D’Elia, G. (2011). Perceptions of and Attitudes toward Antidepressants. Journal of Nervous & Mental Disease, 199, 866-871. https://doi.org/10.1097/nmd.0b013e3182388950
[11]
Ching, P., Hsu, T., Chen, G., Pan, C., Chu, C., & Chou, P. (2022). Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis. Frontiers in Psychiatry, 13, Article 899040. https://doi.org/10.3389/fpsyt.2022.899040
[12]
Culpepper, L. (2009). Generalized Anxiety Disorder and Medical Illness. The Journal of Clinical Psychiatry, 70, 20-24. https://doi.org/10.4088/jcp.s.7002.04
[13]
Davies, J., & Read, J. (2019). A Systematic Review into the Incidence, Severity and Duration of Antidepressant Withdrawal Effects: Are Guidelines Evidence-Based? Addictive Behaviors, 97, 111-121. https://doi.org/10.1016/j.addbeh.2018.08.027
[14]
Drinkwater, C., Wildman, J., & Moffatt, S. (2019). Social Prescribing. British Medical Journal, 364, Article 11285. https://doi.org/10.1136/bmj.l1285
[15]
Griffiths, C. A., & Griffiths, L. J. (2014). Recovery and Reliable Change Rates for Patients Scoring Severe on Depression, Anxiety or Impaired Functioning in a Psychological Therapies Service: IAPT. Mental Health Review Journal, 20, 28-35. https://doi.org/10.1108/mhrj-06-2014-0022
[16]
Griffiths, C., da Silva, K., Jiang, H., Walker, K., Smart, D., Zafar, A. et al. (2023). Alpha-stim AID Cranial Electrotherapy Stimulation (CES) Anxiety Treatment: Anxiety, Depression and Health-Related Quality-of-Life Outcomes in Primary Health-Care Social Prescribing Services. Mental Health Review Journal, 28, 337-349. https://doi.org/10.1108/mhrj-11-2022-0068
[17]
Griffiths, C., Leathlean, C., Smart, D., Zafar, A., Hall, C., & Deeks, S. (2021). Alpha-Stim Cranial Electrotherapy Stimulation (CES) for Anxiety Treatment: Outcomes in a United Kingdom (UK) Primary Care Practice. Open Journal of Psychiatry, 11, 186-201. https://doi.org/10.4236/ojpsych.2021.113015
[18]
Guleyupoglu, B., Schestatsky, P., Edwards, D., Fregni, F., & Bikson, M. (2013). Classification of Methods in Transcranial Electrical Stimulation (tES) and Evolving Strategy from Historical Approaches to Contemporary Innovations. Journal of Neuroscience Methods, 219, 297-311. https://doi.org/10.1016/j.jneumeth.2013.07.016
[19]
Gyani, A., Shafran, R., Layard, R., & Clark, D. M. (2013). Enhancing Recovery Rates: Lessons from Year One of IAPT. Behaviour Research and Therapy, 51, 597-606. https://doi.org/10.1016/j.brat.2013.06.004
[20]
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019). Systematic Review and Meta-Analysis: Dose-Response Curve of SSRIs and SNRIs in Anxiety Disorders. Depression and Anxiety, 36, 198-212. https://doi.org/10.1002/da.22854
[21]
Jiménez-Jiménez, F. J., & Molina, J. A. (2000). Extrapyramidal Symptoms Associated with Selective Serotonin Reuptake Inhibitors. CNS Drugs, 14, 367-379. https://doi.org/10.2165/00023210-200014050-00004
[22]
Kennerly, R. (2004). QEEG Analysis of Cranial Electrotherapy: A Pilot Study. Journal of Neurotherapy, 8, 112-113.
[23]
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012). Twelve-Month and Lifetime Prevalence and Lifetime Morbid Risk of Anxiety and Mood Disorders in the United States. International Journal of Methods in Psychiatric Research, 21, 169-184. https://doi.org/10.1002/mpr.1359
[24]
Kim, J., Kim, H., Kim, D., Lee, S., Roh, J. Y., Kim, C. et al. (2021). Effects of Cranial Electrotherapy Stimulation with Novel In-Ear Electrodes on Anxiety and Resting-State Brain Activity: A Randomized Double-Blind Placebo-Controlled Trial. Journal of Affective Disorders, 295, 856-864. https://doi.org/10.1016/j.jad.2021.08.141
[25]
Kirsch, T. B., Kuhn, J., Price, L. R., Marksberry, J., & Haltiwanger, S. G. (2019) A Novel Medical Device that Relieves Anxiety, Depression and Pain While Improving Sleep in a Population of Teachers. Journal of Depression and Anxiety, 8, Article 334.
[26]
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9. Journal of General Internal Medicine, 16, 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
[27]
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007). Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection. Annals of Internal Medicine, 146, 317-325. https://doi.org/10.7326/0003-4819-146-5-200703060-00004
[28]
Locke, A. B., Kirst, N., & Shultz, C. G. (2015). Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician, 91, 617-624.
[29]
Mark, T. L., Joish, V. N., Hay, J. W., Sheehan, D. V., Johnston, S. S., & Cao, Z. (2011). Antidepressant Use in Geriatric Populations: The Burden of Side Effects and Interactions and Their Impact on Adherence and Costs. The American Journal of Geriatric Psychiatry, 19, 211-221. https://doi.org/10.1097/jgp.0b013e3181f1803d
[30]
Michael, T., Zetsche, U., & Margraf, J. (2007). Epidemiology of Anxiety Disorders. Psychiatry, 6, 136-142. https://doi.org/10.1016/j.mppsy.2007.01.007
[31]
Mochcovitch, M. D., da Rocha Freire, R. C., Garcia, R. F., & Nardi, A. E. (2017). Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review. Clinical Drug Investigation, 37, 737-743. https://doi.org/10.1007/s40261-017-0528-x
[32]
Morriss, R., Patel, S., Boutry, C., Patel, P., Guo, B., Briley, P. M. et al. (2023). Clinical Effectiveness of Active Alpha-Stim AID versus Sham Alpha-Stim AID in Major Depression in Primary Care in England (Alpha-Stim-D): A Multicentre, Parallel Group, Double-Blind, Randomized Controlled Trial. The Lancet Psychiatry, 10, 172-183. https://doi.org/10.1016/s2215-0366(23)00007-x
[33]
Morriss, R., Xydopoulos, G., Craven, M., Price, L., & Fordham, R. (2019). Clinical Effectiveness and Cost Minimisation Model of Alpha-Stim Cranial Electrotherapy Stimulation in Treatment Seeking Patients with Moderate to Severe Generalised Anxiety Disorder. Journal of Affective Disorders, 253, 426-437. https://doi.org/10.1016/j.jad.2019.04.020
[34]
Muntingh, A. D., van der Feltz-Cornelis, C. M., van Marwijk, H. W., Spinhoven, P., & van Balkom, A. J. (2016). Collaborative Care for Anxiety Disorders in Primary Care: A Systematic Review and Meta-Analysis. BMC Family Practice, 17, 1-15. https://doi.org/10.1186/s12875-016-0466-3
[35]
Nardone, R., Höller, Y., Leis, S., Höller, P., Thon, N., Thomschewski, A. et al. (2014). Invasive and Non-Invasive Brain Stimulation for Treatment of Neuropathic Pain in Patients with Spinal Cord Injury: A Review. The Journal of Spinal Cord Medicine, 37, 19-31. https://doi.org/10.1179/2045772313y.0000000140
[36]
NHS (2019). The NHS Long Term Plan. https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf
[37]
NHS England (2021). Social Prescribing. https://www.england.nhs.uk/personalisedcare/social-prescribing/
[38]
NICE (2019a). Benzodiazepine and Z-Drug Withdrawal. https://cks.nice.org.uk/topics/benzodiazepine-z-drug-withdrawal/
[39]
NICE (2019b). Generalised Anxiety Disorder and Panic Disorder in Adults: Management. Clinical Guideline. https://www.nice.org.uk/guidance/cg113
[40]
NICE (2021). Alpha-Stim AID for Anxiety Disorders. Medical Technologies Guidance. https://www.nice.org.uk/guidance/mtg56
[41]
Richards, D. A., & Borglin, G. (2011). Implementation of Psychological Therapies for Anxiety and Depression in Routine Practice: Two Year Prospective Cohort Study. Journal of Affective Disorders, 133, 51-60. https://doi.org/10.1016/j.jad.2011.03.024
[42]
Royal, S., Keeling, S., Kelsall, N., Price, L., Fordham, R., Xydopoulos, G. et al. (2022). Feasibility, Acceptability and Costs of Nurse-Led Alpha-Stim Cranial Electrostimulation to Treat Anxiety and Depression in University Students. BMC Primary Care, 23, Article No. 97. https://doi.org/10.1186/s12875-022-01681-3
[43]
Shekelle, P. G., Cook, I. A., Miake-Lye, I. M., Booth, M. S., Beroes, J. M., & Mak, S. (2018). Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia. Annals of Internal Medicine, 168, 414-421. https://doi.org/10.7326/m17-1970
[44]
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A Brief Measure for Assessing Generalized Anxiety Disorder. Archives of Internal Medicine, 166, 1092-1097. https://doi.org/10.1001/archinte.166.10.1092
[45]
Strawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018). Pharmacotherapy for Generalized Anxiety Disorder in Adult and Pediatric Patients: An Evidence-Based Treatment Review. Expert Opinion on Pharmacotherapy, 19, 1057-1070. https://doi.org/10.1080/14656566.2018.1491966
[46]
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B. et al. (2011). The Size and Burden of Mental Disorders and Other Disorders of the Brain in Europe 2010. European Neuropsychopharmacology, 21, 655-679. https://doi.org/10.1016/j.euroneuro.2011.07.018
